These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1972630)

  • 1. Natural killer cell activity in workers exposed to benzidine and beta-naphthylamine.
    Tanigawa T; Araki S; Ishizu S; Morita T; Okazaki H; Minato N
    Br J Ind Med; 1990 May; 47(5):338-41. PubMed ID: 1972630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase in CD57 + CD16-lymphocytes in workers exposed to benzidine and beta-naphthylamine: assessment of natural killer cell subpopulations.
    Tanigawa T; Araki S; Abo T; Sakurai S
    Int Arch Occup Environ Health; 1996; 69(1):69-72. PubMed ID: 9017438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphocyte reactivity of workers exposed to carcinogenic and non-carcinogenic chemicals.
    Kumar S; Taylor G; Hurst W; Wilson P; Costello CB
    Br J Ind Med; 1981 May; 38(2):167-9. PubMed ID: 7236542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decrease of CD4-positive T lymphocytes in workers exposed to benzidine and beta-naphthylamine.
    Araki S; Tanigawa T; Ishizu S; Minato N
    Arch Environ Health; 1993; 48(4):205-8. PubMed ID: 8102843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent elevation of tissue polypeptide antigen in the sera of workers exposed to bladder carcinogens.
    Kumar S; Wilson P; Brenchley P; Taylor G; Björklund B; Eklund G
    Int J Cancer; 1978 Nov; 22(5):542-5. PubMed ID: 82541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple primary cancers following exposure to benzidine and beta-naphthylamine.
    Morinaga K; Oshima A; Hara I
    Am J Ind Med; 1982; 3(3):243-6. PubMed ID: 7171086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer occurrence among dyestuff workers exposed to aromatic amines. A long term follow-up study.
    Naito S; Tanaka K; Koga H; Kotoh S; Hirohata T; Kumazawa J
    Cancer; 1995 Oct; 76(8):1445-52. PubMed ID: 8620422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Present status and background of occupational uroepithelial tumors].
    Tachibana M; Tazaki H; Murai M; Yamaguch N
    Hinyokika Kiyo; 1989 Dec; 35(12):2003-9. PubMed ID: 2618898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Retrospective analysis of carcinogenic hazards of beta naphthylamine and benzidine production as a stage of an epidemiological study of tumors in workers engaged in aniline dye industry].
    Bul'bulian MA; Gol'dfarb AN
    Gig Tr Prof Zabol; 1991; (7):39-41. PubMed ID: 1916415
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunosurveillance in pre-malignant occupational bladder disease.
    Taylor G; Kumar S; Brenchley P; Wilson P; Costello B; Shaw GH
    Int J Cancer; 1979 Apr; 23(4):487-93. PubMed ID: 86524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumours of the urinary bladder in workmen engaged in the manufacture and use of certain dyestuff intermediates in the British chemical industry. I. The role of aniline, benzidine, alpha-naphthylamine, and beta-naphthylamine.
    CASE RA; HOSKER ME; McDONALD DB; PEARSON JT
    Br J Ind Med; 1954 Apr; 11(2):75-104. PubMed ID: 13149741
    [No Abstract]   [Full Text] [Related]  

  • 12. [Occupational uroepithelial cancer: current status in Wakayama city and clinical study].
    Morimoto S; Uekado Y; Aoshi H; Hirano A; Shinka T; Ohkawa T; Fujinaga T; Nakamura J
    Hinyokika Kiyo; 1989 Dec; 35(12):2015-22. PubMed ID: 2618900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Notification and risk assessment for bladder cancer of a cohort exposed to aromatic amines. III. Mortality among workers exposed to aromatic amines in the last beta-naphthylamine manufacturing facility in the United States.
    Stern FB; Murthy LI; Beaumont JJ; Schulte PA; Halperin WE
    J Occup Med; 1985 Jul; 27(7):495-500. PubMed ID: 4032086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re-evaluation of the latent period of bladder cancer in dyestuff-plant workers in Japan.
    Miyakawa M; Tachibana M; Miyakawa A; Yoshida K; Shimada N; Murai M; Kondo T
    Int J Urol; 2001 Aug; 8(8):423-30. PubMed ID: 11555006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Occupation and urothelial cancer: the background and the clinical figure].
    Itatani H
    Hinyokika Kiyo; 1989 Dec; 35(12):2011-4. PubMed ID: 2618899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bladder cancer mortality of workers exposed to aromatic amines: an updated analysis.
    Piolatto G; Negri E; La Vecchia C; Pira E; Decarli A; Peto J
    Br J Cancer; 1991 Mar; 63(3):457-9. PubMed ID: 2003988
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical study of occupational uroepithelial cancer].
    Hamasaki T; Aramaki K; Hida T; Inatomi H; Fujimoto N; Okamura T; Ozu K; Sugita A
    J UOEH; 1996 Dec; 18(4):247-59. PubMed ID: 8981648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical study on occupational uroepithelial cancer in Wakayama City.
    Ohkawa T; Fujinaga T; Doi J; Ebisuno S; Takamatsu M; Nakamura J; Kido R
    J Urol; 1982 Sep; 128(3):520-3. PubMed ID: 7120557
    [No Abstract]   [Full Text] [Related]  

  • 19. Exposure to aromatic amines and ras and c-erbB-2 overexpression in bladder cancer.
    Novara R; Coda R; Martone T; Vineis P
    J Occup Environ Med; 1996 Apr; 38(4):390-3. PubMed ID: 8925323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic importance of specific immunoreactivity in occupational bladder cancer.
    Kumar S; Taylor G; Wilson P; Hurst W
    Br Med J; 1980 Feb; 280(6213):512-3. PubMed ID: 7370564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.